Please use this identifier to cite or link to this item:
|Title:||Quinidine does not affect the renal clearance of moxonidine|
|Authors:||Wise, S.D. |
|Source:||Wise, S.D., Chan, C., Schaefer, H.G., He, M.M., Pouliquen, I.J., Mitchell, M.I. (2002). Quinidine does not affect the renal clearance of moxonidine. British Journal of Clinical Pharmacology 54 (3) : 251-254. ScholarBank@NUS Repository. https://doi.org/10.1046/j.1365-2125.2002.01647.x|
|Abstract:||Aims: To test the hypothesis that the renal clearance of moxonidine decreases when dosed with quinidine. Methods: A randomized, two-period study was conducted with six healthy, male subjects orally dosed with either 0.2 mg moxonidine alone or 1 h after 400 mg quinidine sulphate. Pharmacokinetic parameters were calculated using a noncompartmental analysis method. Results: When coadministered, quinidine significantly increased moxonidine AUC and t1/2 by 11% and 15%, respectively, and decreased CL/F by 10% compared with the control dosing. CLR and Aeur were not significantly different. Clinically, both treatments were well tolerated. Conclusions: Quinidine does not affect the renal clearance of moxonidine. The decrease in apparent total clearance of moxonidine with quinidine coadministration was possibly due to metabolic inhibition, though not likely to be clinically significant.|
|Source Title:||British Journal of Clinical Pharmacology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 14, 2018
WEB OF SCIENCETM
checked on Jan 17, 2018
checked on Feb 19, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.